Friday, March 24, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Lawrence Livermore Announces Licensing Opportunity for Fast PCR Technology

by Global Biodefense Staff
May 21, 2013

Lawrence Livermore National Laboratory (LLNL), operated by the Lawrence Livermore National Security (LLNS), LLC under contract with the U.S. Department of Energy, is offering an opportunity to license intellectual property for a new Fast PCR Instrument technology for commercialization.

The invention is a microfluidic PCR thermal cycling method capable of extremely fast cycles, and a resulting extremely fast detection time. The technology utilizes a robust, stable and precise temperature control system to cycle the DNA microchip at heating and cooling rates greater than 150 deg/sec without overshoot or undershoot.

The architecture is compact, and allows for optical interrogation, resulting in a field-portable, rapid real-time PCR system. It is estimated that with this method, target nucleic acid templates approaching 1 Kb in length can be amplified under five minutes. These technologies are currently being prototyped at LLNL.

The technology is described in the publication, “Under-three minute PCR: Probing the limits of fast amplification” (The Analyst, 2011, 136, 3707-3712). 

LLNL is seeking industry partners with a demonstrated ability to bring such inventions to the market. Interested parties are requested to contact LLNL via their tech transfer Industrial Partnerships Office website.

Further details are available under Solicitation Number: FBO269-13. Responses are encouraged to be submitted by June 3, 2013. 

Related Posts

small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development
Industry News

DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development

January 10, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Researcher holds a pipette
Biodetection

These Nanotech Bubbles Burst When They Detect Viruses in the Air

October 25, 2022
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy